Saltoro Capital, LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0. A total of 9 filers reported holding ACORDA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
Saltoro Capital, LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$877,500
-10.6%
1,500,0000.0%0.79%
-21.6%
Q2 2023$981,750
-0.9%
1,500,0000.0%1.01%
+63.8%
Q1 2023$991,164
-11.9%
1,500,0000.0%0.61%
-31.6%
Q4 2022$1,124,954
+1.3%
1,500,0000.0%0.90%
+99.1%
Q3 2022$1,110,0000.0%1,500,0000.0%0.45%
+69.5%
Q2 2022$1,110,000
-2.4%
1,500,0000.0%0.27%0.0%
Q1 2022$1,137,000
-7.0%
1,500,0000.0%0.27%
+16.7%
Q4 2021$1,223,0000.0%1,500,0000.0%0.23%
-47.2%
Q3 2021$1,223,000
+10.2%
1,500,0000.0%0.43%
-3.8%
Q2 2021$1,110,000
+2.1%
1,500,0000.0%0.45%
+65.1%
Q1 2021$1,087,0001,500,0000.27%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 25,875,000$15,266,2501.51%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 45,283,000$30,905,6481.28%
Saltoro Capital, LP 1,500,000$877,5000.79%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 30,000,000$19,200,0000.48%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 52,324,000$28,244,1460.45%
Soros Fund Management 27,951,000$15,512,8050.22%
D. E. Shaw & Co., Inc. 14,000,000$7,980,0000.01%
WELLS FARGO & COMPANY/MN 5,018,000$3,424,7850.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACORDA THERAPEUTICS INC shareholders